In addition, studies have revealed that LncRNA ZFAS1/RAB22A in atherosclerosis [34], LINC01320 in gastric cancer [35], Lnc-LSG1 and LncRNA NEAT1 in renal cell carcinoma [36, 37], LncRNA MIR155HG in hepatocellular carcinoma were also regulated by METTL14-mediated m6A modification [38], indicating that METTL14 can regulate the modification of m6A on various LncRNAs, therefore participating in the genesis and development of various tumors. This evidence concerns the gene NEAT1 and hepatocellular carcinoma.